Drug Repurposing of the Antiviral Drug Acyclovir: New Pharmaceutical Salts
Drug repurposing is becoming interesting in terms of offering advantages over the traditional drug development, once drug discovery is a costly, time-consuming, and highly risky process. In particular, with the coronavirus disease (COVID-19) declared by World Health Organization as a global pandemic...
Main Authors: | Paulo Nunes, Pedro Henrique de Oliveira Santiago, Cecilia Carolina Pinheiro da Silva, Javier Ellena |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-05-01
|
Series: | Crystals |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4352/13/5/782 |
Similar Items
-
Drug Repurposing in the COVID-19 Era: Insights from Case Studies Showing Pharmaceutical Peculiarities
by: Milo Gatti, et al.
Published: (2021-02-01) -
Pharmaceutical salts and co-crystals /
by: Wouters, Johan, et al.
Published: (c201) -
A review on drug repurposing in COVID-19: from antiviral drugs to herbal alternatives
by: Abas Sezer, et al.
Published: (2022-05-01) -
Repurposing old drugs as antiviral agents for coronaviruses
by: Cheng-Wei Yang, et al.
Published: (2020-08-01) -
In Vitro Drug Repurposing: Focus on Vasodilators
by: Eduarda Ribeiro, et al.
Published: (2023-02-01)